Bilateral acute retinal necrosis during treatment with alemtuzumab for multiple sclerosis.
Matteo MeneanAlessandro MarcheseAlessandro BordatoMarco BattistaFrancesco Maria BandelloGiulio ModoratiElisabetta MiserocchiPublished in: European journal of ophthalmology (2021)
This report shows a unique case of bilateral ARN caused by VZV associated with alemtuzumab. Any visual loss in MS patients under biologic therapy should not be underestimated, performing an accurate differential diagnosis with optic neuritis.
Keyphrases
- multiple sclerosis
- end stage renal disease
- optical coherence tomography
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mass spectrometry
- liver failure
- prognostic factors
- optic nerve
- peritoneal dialysis
- ms ms
- white matter
- intensive care unit
- hepatitis b virus
- drug induced
- bone marrow
- respiratory failure
- patient reported outcomes
- patient reported